Home > Healthcare > Biotechnology > Biotechnology R&D > Non-animal Alternative Testing Market
Pre-clinical studies give information on the safety and efficacy of a potential drug prior to testing it on humans. Such research involves proper preclinical models to compare it to the real-world population in order to obtain accurate results. Studies on animals are helping researchers discover regarding potential drug toxicity and dosing. As a result, the demand for drug research and development grows as well as the demand for animal models also increases, thereby fostering the market trends.
Further, PETA and Cruelty-Free International agencies are pressurising on the end-user industry to switch animal models to the alternate methods that ensure no animals are harmed, abused, or used in any way that affects the animal as well as people's sentiments. Hence, the awareness pertaining to non-animal alternative testing will propel the market outlook.